Mechanisms of Continued Tolerance Breakdown in Autoimmunity
自身免疫耐受持续崩溃的机制
基本信息
- 批准号:7456501
- 负责人:
- 金额:$ 18.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntigensAtypical lymphocyteAutoantigensAutoimmune DiseasesAutoimmunityB cell differentiationB-LymphocytesBorrelia burgdorferiCellsChronicCollagen ArthritisCollagen Type IIDiseaseDisease ProgressionEnvironmentGastritisGenerationsHashimoto DiseaseHelicobacter pyloriHepatitis CHybridomasInduction of ApoptosisInfectionInflammationInflammatoryLyme DiseaseLymphocyteLymphocytic InfiltrateLymphoidLymphoid FollicleLymphoid TissueMemory B-LymphocyteMusMyasthenia GravisOrganogenesisPathogenesisPatientsPlayProcessPropertyReactionResearch InfrastructureRheumatoid ArthritisRoleSelf ToleranceSeverity of illnessSiteSjogren&aposs SyndromeStructureStructure of germinal center of lymph nodeSyndromeTestingTissuesimmunogenicityresponse
项目摘要
DESCRIPTION (provided by applicant): In chronic inflammation, lymphocytes are not restricted to lymphoid tissues but often infiltrate and accumulate in affected tissues. These lymphocytic infiltrates present in various affected nonlymphoid tissues can form tertiary lymphoid structures by a process called lymphoid neogenesis or ectopic lymphoid organogenesis. These tertiary lymphoid structures are found in many autoimmune diseases including rheumatoid arthritis, Hashimoto's thyroiditis, Sj"gren's syndrome, and Myasthenia gravis. In addition, in chronic infections such as Helicobacter pylori gastritis, hepatitis C, and Borrelia burgdorferi caused Lyme disease, ectopic lymphoid structures can also be frequently found in affected tissues. It has been suggested that the process of lymphoid neogenesis from non-organized infiltrates to GC reaction in autoimmune diseases is associated with increased disease severity and accelerated breakdown in self-tolerance. We hypothesize that lymphocytes in ectopic lymphoid microstructures are reactive or cross-reactive with auto-antigens. The local environment of these specialized tertiary lymphoid structures may trap and enrich antigens that are not initially involved in the disease process and provide an infrastructure to support responses/against self-antigens. Thus, these outposts of lymphoid structures at the inflammatory sites not only play an important role in the loss of self-tolerance, but also are critical in disease progression. We will also test the hypothesis that, due to the unique property of local microenvironment, lymphocytes in ectopic lymphoid structures in inflamed tissues may alter their sensitivity to apoptosis induction and escape the censorship of self-reactive lymphocytes. Therefore, we propose the following specific aims: Aim 1. To evaluate the properties of apoptosis induction in lymphocyte infiltrates in local inflamed tissues. Aim 2. To determine if the local autoreactive response is maintained by reactivity to the initiating antigen. Aim 3. To define the antigen reactivity and ability to transfer disease of hybridomas generated from infiltrating B cells.
描述(由申请人提供):在慢性炎症中,淋巴细胞不限于淋巴组织,而是通常浸润并在受影响的组织中积累。这些淋巴细胞浸润物存在于各种受影响的非淋巴组织中,可以通过称为淋巴新生殖或异位淋巴管风机发生的过程形成三级淋巴结构。 These tertiary lymphoid structures are found in many autoimmune diseases including rheumatoid arthritis, Hashimoto's thyroiditis, Sj"gren's syndrome, and Myasthenia gravis. In addition, in chronic infections such as Helicobacter pylori gastritis, hepatitis C, and Borrelia burgdorferi caused Lyme disease, ectopic lymphoid在受影响的组织中也经常发现结构这些专业的三级淋巴结构的环境可能会捕获并富集最初参与疾病过程的抗原,并提供支持反应/对自我抗原的反应的基础设施,因此,这些在炎症部位的淋巴结结构的前哨不仅在自我体育疾病中起重要作用,而且在疾病中也起着重要作用。我们还将检验以下假设:由于局部微环境的独特特性,发炎组织中异位淋巴样结构中的淋巴细胞可能会改变其对凋亡诱导的敏感性并避免自反应性淋巴细胞的审查。因此,我们提出以下特定目的:目标1。评估局部发炎组织中淋巴细胞浸润中凋亡诱导的特性。目标2。确定是否通过对启动抗原的反应性来维持局部自动反应。目的3。定义抗原反应性和转移由浸润B细胞产生的杂交瘤疾病的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Biao Zheng其他文献
Biao Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Biao Zheng', 18)}}的其他基金
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
8128041 - 财政年份:2010
- 资助金额:
$ 18.82万 - 项目类别:
Mechanisms of Continued Tolerance Breakdown in Autoimmunity
自身免疫耐受持续崩溃的机制
- 批准号:
7212509 - 财政年份:2007
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
7281506 - 财政年份:2006
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
7070016 - 财政年份:2005
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
7386530 - 财政年份:2005
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
6969519 - 财政年份:2005
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
7595082 - 财政年份:2005
- 资助金额:
$ 18.82万 - 项目类别:
Fc Receptor Signaling in Vaccine Design for the Elderly
老年人疫苗设计中的 Fc 受体信号转导
- 批准号:
7196535 - 财政年份:2005
- 资助金额:
$ 18.82万 - 项目类别:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
免疫衰老和生发中心反应改变
- 批准号:
6706691 - 财政年份:1999
- 资助金额:
$ 18.82万 - 项目类别:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
免疫衰老和生发中心反应改变
- 批准号:
6135462 - 财政年份:1999
- 资助金额:
$ 18.82万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向KRAS新抗原TCR-T细胞的亲和力优化和抗肿瘤功能分析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向KRAS新抗原TCR-T细胞的亲和力优化和抗肿瘤功能分析
- 批准号:82202991
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
- 批准号:32102067
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
免疫分析异源竞争模式中半抗原设计机制研究
- 批准号:31800776
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
Development of a rapid screening test for the detection of dihydroanatoxin-a
开发检测二氢虾毒素-a 的快速筛选试验
- 批准号:
10545266 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别: